Subscribe

Episode Guide: Eli Lilly's GLP-1 Bet: Internal Science vs. Market Hype

Eli Lilly's strategic focus on the internal science of GLP-1s, rather than external market hype, highlights a growing trend.

· 7 min read

Topics

Get this desk in your inbox

Free, and you pick which desks. We listen to 300+ business podcasts a week so you don't have to.

Pick your desks

More from this desk

All briefings